For more information, visit: miltenyibiotec.com/reprogrammingworkflow Join us for an informative webinar on induced pluripotent stem cells (iPSCs), shedding light on various reprogramming methods and their significance, while introducing the new reprogramming workflow, inclusive of the newly released StemMACS™ iPSC mRNA Reprogramming Kit, human, from Miltenyi Biotec.
Discover the revolutionary mRNA reprogramming technique and its myriad of benefits, including enhanced efficiency, safety, and reproducibility, in a streamlined process ensuring high-quality iPSCs. Join Hannah Johannsen and Parivash Nouri as they provide a comprehensive overview of the entire reprogramming workflow - from fibroblast collection to iPSC generation, isolation, and crucial quality control.
Finally, Dr. Sebastian Diecke from the Max Delbrück Center in Berlin will showcase outcomes achieved through the application of the StemMACS iPSC mRNA Reprogramming Kit, human.
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies enable solutions for cellular research, cell therapy, cell manufacturing, and imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 3,000 employees in 28 countries - all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.